Enzon Pharmaceuticals Inc
OTC:ENZN
Enzon Pharmaceuticals Inc
OTC:ENZN
Price:
6
USD
8.11%
Market Closed
Market Cap:
$4.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Enzon Pharmaceuticals Inc
OTC:ENZN
|
US |
|
Hind Rectifiers Ltd
NSE:HIRECT
|
IN |
|
J
|
JEP Holdings Ltd
SGX:1J4
|
SG |
|
Qudian Inc
NYSE:QD
|
CN |
|
Kino Indonesia Tbk PT
IDX:KINO
|
ID |
|
Tamboran Resources Ltd
ASX:TBN
|
AU |
|
Azbil Corp
TSE:6845
|
JP |
|
Tigers Polymer Corp
TSE:4231
|
JP |
|
M
|
Meshek Energy-Renewable Energies Ltd
TASE:MSKE
|
IL |
|
Li Auto Inc
HKEX:2015
|
CN |
|
GigaDevice Semiconductor Inc
SSE:603986
|
CN |
Balance Sheet
Balance Sheet Decomposition
Enzon Pharmaceuticals Inc
Enzon Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Enzon Pharmaceuticals Inc
Enzon Pharmaceuticals Inc
Balance Sheet
Enzon Pharmaceuticals Inc
Enzon Pharmaceuticals Inc
Currency: USD
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
77
|
21
|
40
|
80
|
50
|
398
|
104
|
77
|
7
|
35
|
12
|
8
|
8
|
7
|
5
|
48
|
48
|
47
|
47
|
47
|
43
|
|
| Cash Equivalents |
77
|
21
|
40
|
80
|
50
|
398
|
104
|
77
|
7
|
35
|
12
|
8
|
8
|
7
|
5
|
48
|
48
|
47
|
47
|
47
|
43
|
|
| Short-Term Investments |
94
|
153
|
124
|
65
|
54
|
31
|
58
|
119
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
14
|
15
|
15
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
14
|
15
|
15
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
16
|
18
|
22
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
6
|
6
|
80
|
5
|
41
|
6
|
3
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
207
|
212
|
281
|
177
|
145
|
435
|
165
|
199
|
7
|
35
|
12
|
8
|
8
|
15
|
6
|
48
|
48
|
47
|
47
|
47
|
43
|
|
| PP&E Net |
35
|
40
|
45
|
45
|
27
|
22
|
17
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
35
|
40
|
45
|
45
|
27
|
22
|
17
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
22
|
27
|
37
|
40
|
36
|
38
|
41
|
26
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
34
|
79
|
68
|
61
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
62
|
67
|
21
|
63
|
96
|
31
|
161
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
3
|
7
|
5
|
4
|
65
|
1
|
0
|
0
|
0
|
0
|
11
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
341
N/A
|
404
+18%
|
420
+4%
|
349
-17%
|
333
-5%
|
489
+47%
|
343
-30%
|
200
-42%
|
7
-96%
|
35
+393%
|
23
-35%
|
11
-51%
|
10
-16%
|
16
+63%
|
7
-58%
|
48
+642%
|
48
-1%
|
48
0%
|
48
+0%
|
47
-1%
|
43
-9%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
10
|
25
|
9
|
4
|
1
|
4
|
2
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
20
|
35
|
24
|
29
|
10
|
14
|
14
|
6
|
1
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
116
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
72
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
0
|
0
|
13
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Total Current Liabilities |
31
|
60
|
106
|
36
|
25
|
18
|
15
|
122
|
1
|
5
|
5
|
1
|
0
|
1
|
0
|
0
|
0
|
2
|
2
|
2
|
1
|
|
| Long-Term Debt |
394
|
398
|
275
|
268
|
250
|
135
|
130
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
3
|
3
|
4
|
4
|
4
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
425
N/A
|
460
+8%
|
384
-17%
|
308
-20%
|
280
-9%
|
157
-44%
|
146
-7%
|
122
-16%
|
2
-98%
|
5
+184%
|
5
-11%
|
1
-81%
|
0
-56%
|
1
+25%
|
0
-20%
|
0
N/A
|
0
N/A
|
2
+325%
|
2
+1%
|
2
-2%
|
1
-56%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
41
|
43
|
43
|
43
|
43
|
45
|
|
| Retained Earnings |
404
|
383
|
300
|
302
|
302
|
124
|
145
|
148
|
130
|
101
|
79
|
80
|
75
|
69
|
70
|
71
|
72
|
72
|
71
|
70
|
73
|
|
| Additional Paid In Capital |
321
|
326
|
335
|
345
|
352
|
455
|
342
|
225
|
135
|
130
|
97
|
90
|
84
|
84
|
76
|
78
|
76
|
75
|
73
|
72
|
70
|
|
| Other Equity |
1
|
0
|
0
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
84
N/A
|
56
+33%
|
37
N/A
|
42
+14%
|
53
+28%
|
332
+523%
|
197
-41%
|
78
-61%
|
5
-93%
|
30
+458%
|
18
-39%
|
10
-43%
|
9
-12%
|
15
+65%
|
6
-59%
|
48
+684%
|
47
-1%
|
46
-3%
|
46
+0%
|
45
-1%
|
42
-7%
|
|
| Total Liabilities & Equity |
341
N/A
|
404
+18%
|
420
+4%
|
349
-17%
|
333
-5%
|
489
+47%
|
343
-30%
|
200
-42%
|
7
-96%
|
35
+393%
|
23
-35%
|
11
-51%
|
10
-16%
|
16
+63%
|
7
-58%
|
48
+642%
|
48
-1%
|
48
0%
|
48
+0%
|
47
-1%
|
43
-9%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
44
|
44
|
44
|
45
|
45
|
59
|
48
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
74
|
74
|
74
|
74
|
74
|
74
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
